ArticleOpen forum infectious diseases2020

Clinical Management of Respiratory Adverse Events Associated With Amikacin Liposome Inhalation Suspension: Results From a Patient Survey.

Colin Swenson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.